Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy
一项多中心、随机、双盲、安慰剂对照的3期临床试验，旨在评估mogamulizumab治疗人类T细胞白血病病毒1型相关脊髓病患者的疗效，并开展一项开放标签扩展研究。
期刊:Journal of Neurology
影响因子:4.6
doi:10.1007/s00415-024-12239-x
Sato, Tomoo; Nagai, Masahiro; Watanabe, Osamu; Misu, Tatsuro; Takenouchi, Norihiro; Ohkubo, Ryuichi; Ishihara, Satoshi; Tsuboi, Yoshio; Katsuno, Masahisa; Nakagawa, Masanori; Matsushita, Takuya; Aso, Yasuhiro; Matsuura, Eiji; Tokashiki, Takashi; Mukaino, Akihiro; Adachi, Hiroaki; Nakanishi, Kaoru; Yamaguchi, Yusuke; Yamaguchi, Saaya; Yamano, Yoshihisa
T细胞
神经科学
白血病
微生物学
T细胞
细胞生物学
免疫/内分泌
